Cost-effectiveness analysis of the Spanish renal replacement therapy program

Peritoneal Dialysis International

Volumn 32, Issue 2, 2012, Pages 192-199

  Villa, Guillermo ^a   Fernández Ortiz, Lucía ^a   Cuervo, Jesús ^a   Rebollo, Pablo ^a   Selgas, Rafael ^b   González, Teresa ^c   Arrieta, Javier ^d  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; ETHNIC GROUP; HEALTH CARE COST; HEALTH STATUS; HIDDEN MARKOV MODEL; HUMAN; INCIDENCE; KIDNEY FAILURE; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RENAL REPLACEMENT THERAPY; SPANISH;

COST-BENEFIT ANALYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MARKOV CHAINS; MODELS, BIOLOGICAL; RENAL REPLACEMENT THERAPY; SPAIN;

EID: 84857802647     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00037     Document Type: Article

References (23)

1. Villa G, Rodríguez-Carmona A, Fernández-Ortiz L, Cuervo J, Rebollo P, Otero A, et al. Cost analysis of the Spanish renal replacement therapy programme. Nephrol Dial Transplant 2011;:[Epub ahead of print].
2. Arrieta J, Bajo MA, Caravaca F, Coronel F, García-Pérez H, González-Parra E, et al. Guidelines of the Spanish Society of Nephrology. Clinical practice guidelines for peritoneal dialysis (Spanish). Nefrologia 2006; 26(Suppl 4):1-184.
3. Szabo E, Moody H, Hamilton T, Ang C, Kovithavongs C, Kjellstrand C. Choice of treatment improves quality of life. A study on patients undergoing dialysis. Arch Intern Med 1997; 157:1352-6.
4. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2008; 11:733-41.
5. Marrón B, Martínez Ocaña JC, Salgueira M, Barril G, Lamas JM, Martín M, et al. Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int 2005; 25(Suppl 3):S56-9.
6. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M, Sanz P, et al. Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multi center study in Spain (Spanish). Nefrologia 2002; 22:49-59.
7. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Barril G, Salgueira M, et al. Longer pre-dialysis nephrological care is associated with improved long-term survival of dialysis patients. More facts. Nephrol Dial Transplant 2002; 17:1354-5.
8. Roderick P, Jones C, Tomson C, Mason J. Late referral for dialysis: improving the management of chronic renal disease. QJM 2002; 95:363-70.
9. Gallego E, López A, Lorenzo I, López E, Llamas F, Illescas ML, et al. Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis (Spanish). Nefrologia 2003; 23:234-42.
10. Caravaca F, Arrobas M, Luna E, Pizarro JL, García C, Espá-rrago JF, et al. Progression of renal insufficiency in the pre-end-stage renal disease setting (Spanish). Nefrologia 2003; 23:510-19.
11. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003; 41:310-18.
12. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant 2004; 19:1808-14.
13. Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int 2005; 67:1038-46.
14. Alcázar R, Egocheaga MI, Orte L, Lobos JM, González Parra E, Alvarez Guisasola F, et al. SEN-SEMFYC consensus document on chronic kidney disease (Spanish). Nefrologia 2008; 28:273-82.
15. Marrón B, Ortiz A, de Sequera P, Martín-Reyes G, de Arriba G, Lamas JM, et al. Impact of end-stage renal disease in planned dialysis start and type of renal replacement therapy: a Spanish multicentre experience. Nephrol Dial Transplant 2006; 21(Suppl 2):ii51-5.
16. Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Baltar J, Alvarez-Grande J. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant 2005; 20:598-603.
17. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13:397-409.
18. Antolín A, Miguel A, Pérez J, Gómez C, Zurriaga O, Blasco MJ, et al. Analysis of survival in dialysis: hemodialysis versus peritoneal dialysis and the significance of comorbidity (Spanish). Nefrologia 2002; 22:253-61.
19. UNIPAR. Information Unit for Kidney Patients of the cAPV 2005 (Spanish). Vitoria-Gasteiz, Spain: Central Publication Service of the Basque Government; 2006. [Available online at: http://www.osakidetza.euskadi.net/v19-hbas0003/es/contenidos/informacion/hbas_nefrologia/ es_hbas/adjuntos/enfermos_renales_pais_vasco.pdf; accessed 10 May 2011]
20. Rebollo P, Morís J, Ortega T, Valdés C, Ortega F. Estimating utility values for health status using the Spanish version of the SF-36. Validity of the SF-6D index vs EQ-5D (Spanish). Med clin (Barc) 2007; 128:536-7.
21. Cleemput I, Kesteloot K, Vanrenterghem Y, De Geest S. The economic implications of non-adherence after renal transplantation. Pharmacoeconomics 2004; 22:1217-34.
22. Pacheco A, Saffie A, Torres R, Tortella C, Llanos C, Vargas D, et al. Cost-utility study of peritoneal dialysis and he-modialysis in Chile. Perit Dial Int 2007; 27:359-63.
23. Rabindranath KS, Adams J, Ali TZ, MacLeod AM, Vale L, Cody J, et al. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. cochrane Database Syst Rev 2007; (2):CD006515.